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inal microflora. Lactobacilli, bifidobacteria and clostridia were
suppressed significantly, while Bacteroides strains were not mark-
edly affected by the ceftriaxone–loracarbef treatment. Three
patients had Clostridium difficile strains during treatment. The
intestinal microflora was normalized after 24 days. When com-
paring the two treatment groups, no differences were observed
during the first 2 days of treatment. No statistical differences in
the effect on the intestinal microflora between the two treat-
ment regimens were observed.
Loracarbef is a b-lactam antibiotic for oral administration. It
is 90% absorbed from the gastrointestinal tract after oral admin-
istration with or without food. As a result of the absorption,
minor changes in the intestinal microflora after loracarbef
administration have been observed [5]. The stool concentra-
tions of loracarbef are also low, 0–0.9 mg/kg after administra-
tion of loracarbef 200 mg twice daily for 7 days [5]. In contrast,
ceftriaxone is excreted in high concentrations in the bile
(500 mg/L), and pronounced effects on the aerobic and anae-
robic microflora have been reported [7,11].
Ceftriaxone is used in the outpatient treatment of commu-
nity-acquired pneumonia in children and adults with clinical
success [12,13]. However, in order to reduce the ecological
impact of ceftriaxone on the intestinal microflora and the
duration of hospitalization, step-down therapy with an oral
b-lactam agent may be preferable. In the present trial, loracarbef
was used as the oral agent. There was no difference in the
clinical efficacy between the two 12-patient treatment groups,
indicating that step-down therapy of ceftriaxone plus loracarbef
for treatment of community-acquired pneumonia may be
acceptable. However, it should be mentioned that only a small
number of patients were participating in the trial.
In conclusion, step-down therapy with ceftriaxone plus
loracarbef caused similar ecological alterations in the intestinal
microflora to those of parenteral ceftriaxone therapy in patients
with community-acquired pneumonia.
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Infection of implanted plastic devices is one of the most serious
complications in hospitalized patients [1]. The genus Candida
comprises important nosocomial pathogens involved in biofilm
production on catheter and prosthetic materials. The ability of
many strains of the genus Candida to adhere to inert polymeric
surfaces may allow these microorganisms direct access into the
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human host. Yeast adherence appears to be an important step in
the pathogenesis of superficial and systemic candidosis [2].
Candida albicans, C. tropicalis, C. parapsilosis, C. glabrata and
C. lusitaniae have clearly been associated with prolonged cathe-
terization [3,4]. In addition, the clinical relevance of Candida
species other than C. albicans is increasing in compromised
patients [5–9]. The presence of an indwelling catheter con-
tributes to the local enrichment of Candida cells adhering to
plastic material. A catheter-mediated selection occurs with
adherent yeast-phase cells, and both microbial (slime) and host
(fibrin and fibronectin) factors contribute to the formation of
the biofilm, essential for adherence and maintenance of colo-
nization and infection [10]. Therefore, a relationship between
adherence in vitro, biofilm production and Candida invasiveness
may be suspected.
In this study, intraspecific differences in adherence, mostly
related to more invasive strains, were noted. The SYDT method
was demonstrated to be an inexpensive, easy and accurate tool
for quantifying adherence to plastic in vitro. This fact would
help in identifying some isolates producing a biofilm in vivo. A
connection between adherence in vitro, the ability to produce a
biofilm in vivo and catheter-related infection is suggested here.
In total, 103 yeast clinical isolates belonging to the genus
Candida were studied. Eighty-two of them were Candida species
other than C. albicans: C. parapsilosis (37), C. tropicalis (17), C.
glabrata (20), and C. lusitaniae (8). All of them were significant
isolates of these species obtained during the last 2 years in the
Mycology Unit at Ramo´n y Cajal Hospital (Madrid). Within
the C. parapsilosis group, two subsets were analyzed: 20 isolates
recovered from deep-seated locations in bone marrow trans-
plant recipients (15 strains from blood cultures, three from
indwelling catheters, one from an implanted mitral valve,
and one from cerebrospinal fluid), and 17 strains isolated from
epidermal or mucosal sites. Seven isolates of C. tropicalis were
obtained from significant (>100 000 CFU/mL) urine speci-
mens, six from deep respiratory tract secretions, two from
vaginal secretions, and two from wound infections. Nine C.
glabrata isolates were obtained from vaginal infections, six from
significant urine specimens, four from deep respiratory tract
secretions, and one from a blood culture. One isolate of
C. lusitaniae was obtained from an indwelling catheter, and
seven isolates from vaginal and significant urine specimens. All
C. albicans isolates were isolated from vaginal and significant
urine specimens.
Adherence was evaluated by measuring the dye from stained
Candida organisms attached to sterile polystyrene tubes. Isolates
were cultured in Sabouraud Agar plates for 48 h at 30 8C; then,
three colonies were gently suspended in test tubes containing
Sabouraud Broth (Institute Pasteur Production, Marnes
la-Coquette, France) with 8% glucose. The inoculum size
was estimated in about 1.5 107 CFU/mL by immediate plate
counting. Tubes (3 0.5 inches) were incubated at 35 8C with
mild shaking (180 rev/min) for 24 h. Then, the Sabouraud
broth was completely removed, and tube walls were gently
washed (overflow, without shaking) with deionized water and
stained with 2 mL of safranine (4 g/L) alcohol solution (20%).
After 30 s of staining, the safranine solution was removed. Tubes
were allowed to dry for about 2 h in a closed chamber with air
extraction. Direct visual detection (DVD) of stained tubes was
obvious at this stage (three independent observers). A quanti-
tative measurement of adherence was performed by direct
spectrophotometric reading at 560 nm (Bausch and Long Spec-
tronic 20) of stained yeasts in dried tubes (SYDT); for every
tube, the mean optical density (OD) from three readings
corresponding to 1208 rotating positions was calculated. Alter-
natively, before tubes became dry, 3 mL of deionized water was
added, followed by intensive vortexing for enough time to allow
the stained yeast to be completely incorporated in the fluid.
Subsequently, the stained yeast suspension was spectrophoto-
metrically read at 610 nm (SSYS). The test was considered to
be positive when the OD¼ 0.1 by each procedure.
The correlation between DVD and SYDT was excellent: of
50 DVD-positive strains, 45 showed an OD 0.1, and of 53
DVD-negative strains, 51 showed an OD< 0.1. A good cor-
relation between DVD-positive strains and SSYS-positive
strains was also found. Of 50 DVD-positive strains, 49 showed
an OD 0.1. In contrast, of 53 DVD-negative strains, only 16
showed an OD< 0.1. When an OD cut-off of 0.2 was used
by SSYS, 21 DVD-positive strains of 50 were correctly classi-
fied. Given the better correlation of DVD and SYDT, a positive
adherence test was considered when an OD 0.1 by the SYDT
method was obtained, which corresponded to 45.6% of all
studied strains (47/103). The detailed data of adherence for the
different Candida species by SYDT are shown in Table 1.
The spectrophotometric assays used in this study were useful
for quantifying and comparing adherence to plastic material of
different Candida species and revealed significant differences
within the genus. A low frequency of adherent C. glabrata
isolates was found (10%; 2/20), slightly higher than for C.
albicans (4.8%; 1/21). A high degree of adherence was detected
in all C. tropicalis isolates tested (100%; 17/17), and it was the
species that most consistently produced adherence under our
experimental conditions. A better adherence of some strains of
C. tropicalis compared with strains of C. albicans has previously
been described [11]. C. tropicalis is more hydrophobic than
C. albicans in water/hexadecane partition tests, and the better
adherence to plastic surfaces can be related to this fact. A large
number of C. tropicalis isolates (76.5%; 13/17) showed an
OD 0.3, which represents the highest proportion of isolates
with a high adherence level observed with any Candida species
tested. Most C. lusitaniae isolates showed a positive test (87.5%;
7/8). Surprisingly, one C. lusitaniae isolate had an OD greater
than 0.8, suggesting that some isolates may be particularly
adherent. The ability of C. lusitaniae to produce biofilms on
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polystyrene surfaces has never been explored before. The
adherence of this species to plastic may be a frequent trait.
This finding might account for the frequent involvement of C.
lusitaniae in infected catheters. Most C. parapsilosis isolates
adhered to plastic (54%; 20/37). These results obtained with
C. parapsilosis isolates, mostly isolated from bone marrow
transplant recipients, are consistent with those reported by
Branchini et al [12], who found a positive adherence test
(estimated by visual reading) in 80% of the studied isolates.
In our study, if only strains from bone marrow transplant
recipients were considered, a higher value would have been
obtained (65%; 13/20).
Depending on the recovery site, a significant difference in
adherence was found (Table 1), thus indicating intraspecific
variability in all studied species. Interestingly, a higher frequency
of invasive strains (68.7%; 22/32) than those recovered from
epidermal sites (35.2%; 25/71) produced a positive adherence
test. In addition, within each Candida species, the highest OD
values were obtained with the most invasive strains: one C.
lusitaniae from blood culture; three C. parasilopsis from indwel-
ling catheters, one from cerebrospinal fluid, and three from
blood culture; one C. glabrata from blood culture; and five
C. tropicalis from deep respiratory tract secretions.
Many studies have demonstrated the importance of the basal
yeast layer in anchoring the biofilm to the plastic surface [2,13].
A positive correlation between adherence of these organisms to
host epithelial surfaces and adherence to plastic surfaces has
previously been described [14]. In addition, a lower suscept-
ibility of Candida in biofilms to antifungal agents has previously
been reported [10]. All these findings suggest a connection
between the degree of colonization, adherence to polystyrene,
biofilm production in vivo, susceptibility to antifungal agents,
invasiveness and pathogenicity of yeast isolates involved in
infected indwelling catheters and other implanted plastic
devices. Although one of the strengths of our data is that the
study includes an extremely large number of strains and species
of clinical relevance, further studies are obviously warranted to
establish a direct connection between adherence and patho-
genicity.
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Brucellosis is a zoonosis with a worldwide distribution, espe-
cially in the Mediterranean basin, the Arabian peninsula, the
Indian subcontinent, Mexico and Central and South America
[1]. It is a systemic disease, and almost every organ can be
affected. The infection usually manifests itself as a febrile
syndrome with no apparent focus, chills, sweating, arthralgia,
and myalgia. About 30% of patients suffer from some localiza-
tion, most commonly bone and joint involvement [2]. Cardi-
ovascular complications are rare, occurring in less than 2% of
patients with brucellosis; they include endocarditis, myocarditis,
and pericarditis [3]. Brucella endocarditis accounts for the
majority of deaths related to brucellosis [4]. The treatment
for brucella endocarditis has not been well established, basically
because of the low number of reported cases. We herein report
our experience with four cases of brucella endocarditis, discuss
treatment options, and review the pertinent literature.
Between 1987 and 1999, four patients were diagnosed as
having brucella endocarditis at Hamad Medical Corporation.
Diagnosis was based on the presence of vegetations on echo-
cardiography, and further supported by positive blood culture,
culture of infected tissue growing Brucella organisms, or a high
brucella serologic titer of over 1 : 320 dilution. The following
data were collected: age, sex, nationality, occupation, raw milk
ingestion, symptoms, physical findings at presentation, total
white blood cell count, erythrocyte sedimentation rate, serol-
ogy, echocardiography, blood culture, culture of infected tissue,
treatment, complications, and outcome.
The age of the patients ranged between 29 and 40 years.
All patients complained of fever. Other symptoms included
anorexia, cough, and night sweats. One patient had hemiparesis.
The duration of symptoms ranged between 2 weeks and 9
months. All patients had a history of raw milk ingestion. Three
patients had a history of valvular heart disease, and had mechan-
ical valvular prostheses. Physical findings on admission included
fever in all patients, and splenomegaly and right-sided hemi-
paresis in one patient each. None of the patients had evidence
of heart failure on presentation or during follow-up.
All patients had normal white blood cell counts. The ery-
throcyte sedimentation rate was elevated in all patients
(range 33–96 mm/h). Blood culture grew Brucella organisms
in three patients. The brucella antibody titer was elevated in
three patients (range 1280–5120). In one patient, brucella
serology was negative in spite of repeated testing; however,
the blood culture was positive in this patient. Transesophageal
echocardiography showed vegetations in all patients. It also
showed paravalvular leak in two patients and an abscess in one
patient.
One patient with native valve brucella endocarditis was
treated with antibiotics alone. The other three with prosthetic
valve brucella endocarditis were treated with antibiotics and
valve replacement. Details of antibiotic therapy are shown in
Table 1. The indications for valve replacement were failure of
medical treatment in one patient (number 3; vegetations devel-
oped while he was receiving antibiotics), and brucella prosthetic
valve endocarditis in the other two. The duration of antibiotic
treatment was between 10 weeks and 20 weeks. Surgery on the
three patients was carried out 4 days, 10 days, and 11 weeks,
respectively, after starting antibiotic treatment.
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